Do statins reduce the risk of aneurysm development: a case-control study

Clinical article

Restricted access

Object

Recent studies in rats have demonstrated that statins may have an inhibitory effect on intracranial aneurysm (IA) development. The purpose of this study was to assess whether long-term statin use is associated with a reduced risk of IA formation in humans.

Methods

This was a single-center case-control study that included consecutive patients admitted to the authors' institution between January 1, 2005, and December 31, 2008. A case was defined as a patient with a cerebral angiography–confirmed diagnosis of IA. Three controls were matched to each case based on age, sex, and index year of hospital admission. The primary exposure of interest was cumulative statin use. Conditional logistic regression was used to assess the relationship between statin intake and incidence of IA.

Results

In total, 1200 patients were included in the study. No overall association was found between statin use and incidence of IA formation (OR 1.08, 95% CI 0.69–1.69), nor when dichotomized into hydrophilic and lipophilic user, or between short (≤12-month) and long (≥36-month) duration of intake. Hypertension and smoking significantly increased the risk of IA development (OR 4.02, 95% CI 2.49–6.45, and OR 1.67, 95% CI 1.02–2.72, respectively).

Conclusions

In contrast to recent experimental reports of the association between statins and a reduction of IA formation, the authors' findings suggest that in humans statins may have no significant beneficial effect on IA suppression.

Abbreviations used in this paper: AAA = abdominal aortic aneurysm; BMI = body mass index; IA = intracranial aneurysm; SAH = subarachnoid hemorrhage.

Article Information

Address correspondence to: Andreas Raabe, M.D., c/o Publication Office, Susan Wieting, Department of Neurosurgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland. email: susan. wieting@insel.ch.

Please include this information when citing this paper: published online November 25, 2011; DOI: 10.3171/2011.10.JNS11153.

© AANS, except where prohibited by US copyright law.

Headings

References

1

Adams HP JrPutman SFKassell NFTorner JC: Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 41:103310351984

2

Aikawa MRabkin ESugiyama SVoglic SJFukumoto YFurukawa Y: An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103:2762832001

3

Aoki TKataoka HIshibashi RNakagami HNozaki KMorishita R: Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway. Neurosurgery 64:3573662009

4

Aoki TKataoka HIshibashi RNozaki KHashimoto N: Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke 39:127612852008

5

Aoki TKataoka HMoriwaki TNozaki KHashimoto N: Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke 38:233723452007

6

Bradley MCHughes CMCantwell MMMurray LJ: Statins and pancreatic cancer risk: a nested case-control study. Cancer Causes Control 21:209321002010

7

Evans JPowell JTSchwalbe ELoftus IMThompson MM: Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg 34:3023032007

8

Feigin VLRinkel GJLawes CMAlgra ABennett DAvan Gijn J: Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 36:277327802005

9

Ferguson CDClancy PBourke BWalker PJDear ABuckenham T: Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J 159:3073132010

10

Frösen JPiippo APaetau AKangasniemi MNiemelä MHernesniemi J: Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery 58:5345412006

11

Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet 360:7222002

12

Hebert PRGaziano JMChan KSHennekens CH: Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278:3133211997

13

Huang Jvan Gelder JM: The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 51:110111072002

14

Hurks RHoefer IEVink APasterkamp GSchoneveld AKerver M: Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. Eur J Vasc Endovasc Surg 39:5695762010

15

Huttunen Tvon und zu Fraunberg MFrösen JLehecka MTromp GHelin K: Saccular intracranial aneurysm disease: distribution of site, size, and age suggests different etiologies for aneurysm formation and rupture in 316 familial and 1454 sporadic eastern Finnish patients. Neurosurgery 66:6316382010

16

Inagawa T: Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan. J Neurosurg 102:60672005

17

Inagawa T: Size of ruptured intracranial saccular aneurysms in patients in Izumo City, Japan. World Neurosurg 73:8492e112010

18

Johnston SCSelvin SGress DR: The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 50:141314181998

19

Juvela SPoussa KPorras M: Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke 32:4854912001

20

Kalyanasundaram AElmore JRManazer JRGolden AFranklin DPGalt SW: Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg 43:1171242006

21

Koshy LEaswer HVPremkumar SAlapatt JPPillai AMNair S: Risk factors for aneurysmal subarachnoid hemorrhage in an Indian population. Cerebrovasc Dis 29:2682742010

22

Kurth TKase CSBerger KSchaeffner ESBuring JEGaziano JM: Smoking and the risk of hemorrhagic stroke in men. Stroke 34:115111552003

23

Laufs ULa Fata VPlutzky JLiao JK: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:112911351998

24

Mosorin MNiemelä EHeikkinen JLahtinen JTiozzo VSatta J: The use of statins and fate of small abdominal aortic aneurysms. Interact Cardiovasc Thorac Surg 7:5785812008

25

Nagila APermpongpaiboon TTantrarongroj SPorapakkham PChinwattana KDeakin S: Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status. Pharmacol Rep 61:8928982009

26

Nahed BVBydon MOzturk AKBilguvar KBayrakli FGunel M: Genetics of intracranial aneurysms. Neurosurgery 60:2132262007

27

Ruigrok YMRinkel GJ: Genetics of intracranial aneurysms. Stroke 39:104910552008

28

Sandvei MSRomundstad PRMüller TBVatten LVik A: Risk factors for aneurysmal subarachnoid hemorrhage in a prospective population study: the HUNT study in Norway. Stroke 40:195819622009

29

Schlösser FJTangelder MJVerhagen HJvan der Heijden GJMuhs BEvan der Graaf Y: Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg 47:112711332008

30

Schouten Ovan Laanen JHBoersma EVidakovic RFeringa HHDunkelgrün M: Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 32:21262006

31

Shiraya SMiyake TAoki MYoshikazu FOhgi SNishimura M: Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 202:34402009

32

Shu HBAgranoff ABNabel EGLeung KDuckett CSNeish AS: Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol Cell Biol 13:628362891993

33

Steinmetz EFBuckley CShames MLEnnis TLVanvickle-Chavez SJMao D: Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 241:921012005

34

Sukhija RAronow WSSandhu RKakar PBabu S: Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97:2792802006

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 55 55 23
Full Text Views 133 133 9
PDF Downloads 73 73 7
EPUB Downloads 0 0 0

PubMed

Google Scholar